{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:25:25Z","timestamp":1786119925437,"version":"build-2736575974"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1097\/inf.0b013e31821e405d","type":"journal-article","created":{"date-parts":[[2011,5,14]],"date-time":"2011-05-14T07:07:43Z","timestamp":1305356863000},"page":"827-832","source":"Crossref","is-referenced-by-count":34,"title":["Once-daily Gentamicin in Infants and Children"],"prefix":"10.1097","volume":"30","author":[{"given":"Emma J.","family":"Best","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madlen","family":"Gazarian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Cohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Palasanthiran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210202","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1136\/bmj.312.7027.338","article-title":"Single or multiple daily doses of aminoglycosides: a meta-analysis.","volume":"312","author":"Barza","year":"1996","journal-title":"BMJ"},{"key":"R2-4-20210202","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2165\/00003088-199427010-00004","article-title":"What is the evidence for once-daily aminoglycoside therapy?","volume":"27","author":"Barclay","year":"1994","journal-title":"Clin Pharmacokinet"},{"key":"R3-4-20210202","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1093\/clinids\/24.5.796","article-title":"A meta-analysis of the relative efficacy and toxicity of single daily dosing versus multiple daily dosing of aminoglycosides.","volume":"24","author":"Ali","year":"1997","journal-title":"Clin Infect Dis"},{"key":"R4-4-20210202","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/jac\/37.4.645","article-title":"A meta-analysis of studies on the safety and efficacy of aminoglycosides given either once daily or as divided doses.","volume":"37","author":"Munckhof","year":"1996","journal-title":"J Antimicrob Chemother"},{"key":"R5-4-20210202","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1086\/313692","article-title":"National survey of extended-interval aminoglycoside dosing.","volume":"30","author":"Chuck","year":"2000","journal-title":"Clin Infect Dis"},{"key":"R6-4-20210202","doi-asserted-by":"crossref","first-page":"e111","DOI":"10.1542\/peds.114.1.e111","article-title":"Extended-interval aminoglycoside administration for children: a meta-analysis.","volume":"114","author":"Contopoulos-Ioannidis","year":"2004","journal-title":"Pediatrics"},{"key":"R7-4-20210202","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1542\/peds.2004-2425","article-title":"Extended-interval aminoglycosides in children: more guidance is needed.","volume":"115","author":"Best","year":"2005","journal-title":"Pediatrics"},{"key":"R8-4-20210202","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1365-2125.1995.tb05719.x","article-title":"A suggested approach to once-daily aminoglycoside dosing.","volume":"39","author":"Begg","year":"1995","journal-title":"Br J Clin Pharmacol"},{"key":"R9-4-20210202","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1128\/AAC.39.3.650","article-title":"Experience with a once-daily aminoglycoside program administered to 2,184 adult patients.","volume":"39","author":"Nicolau","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"R10-4-20210202","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1136\/adc.80.2.125","article-title":"Once daily ceftriaxone and gentamicin for the treatment of febrile neutropenia.","volume":"80","author":"Tomlinson","year":"1999","journal-title":"Arch Dis Child"},{"key":"R11-4-20210202","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1093\/clinids\/14.1.320","article-title":"A critical reevaluation of the \u201ctherapeutic range\u201d of aminoglycosides.","volume":"14","author":"McCormack","year":"1992","journal-title":"Clin Infect Dis"},{"key":"R13-4-20210202","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0031-3955(16)36251-4","article-title":"The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children and adolescents.","volume":"34","author":"Schwartz","year":"1987","journal-title":"Pediatr Clin North Am"},{"key":"R14-4-20210202","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions.","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"issue":"S1","key":"R15-4-20210202","first-page":"S93","article-title":"Single daily dose of gentamicin in the treatment of pediatric urinary tract infection.","volume":"82","author":"Tapaneya-Olarn","year":"1999","journal-title":"J Med Assoc Thai"},{"key":"R16-4-20210202","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/00007691-200110000-00002","article-title":"Once-daily versus multiple-daily gentamicin in infants and children.","volume":"23","author":"Uijtendaal","year":"2001","journal-title":"Ther Drug Monit"},{"key":"R17-4-20210202","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/00006454-200103000-00004","article-title":"Randomized, controlled trial comparing once daily and three times daily gentamicin in children with urinary tract infections.","volume":"20","author":"Carapetis","year":"2001","journal-title":"Pediatr Infect Dis J"},{"key":"R18-4-20210202","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1128\/AAC.36.7.1499","article-title":"Comparison of 5 milligrams of netilmicin per kilogram of body weight once daily versus 2 milligrams per kilogram thrice daily for treatment of Gram-negative pyelonephritis in children.","volume":"36","author":"Vigano","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"R19-4-20210202","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1093\/clinids\/24.5.820","article-title":"Single daily dose of aminoglycosides\u2013a concept whose time has not yet come.","volume":"24","author":"Bertino","year":"1997","journal-title":"Clin Infect Dis"},{"key":"R20-4-20210202","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1651-2227.2003.tb00548.x","article-title":"Treatment of urinary tract infection with gentamicin once or three times daily.","volume":"92","author":"Chong","year":"2003","journal-title":"Acta Paediatr"},{"key":"R21-4-20210202","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/jac\/13.suppl_A.23","article-title":"Clinical significance of renal changes engendered by aminoglycosides in man.","volume":"13","author":"Luft","year":"1984","journal-title":"J Antimicrob Chemother"},{"key":"R22-4-20210202","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1056\/NEJMra035092","article-title":"Developmental Pharmacology\u2014drug disposition, action and therapy in infants and children.","volume":"349","author":"Kearns","year":"2003","journal-title":"N Engl J Med"},{"key":"R23-4-20210202","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/S0140-6736(05)79447-2","article-title":"Ototoxicity induced by once-daily gentamicin.","volume":"351","author":"El Bakri","year":"1998","journal-title":"Lancet"},{"key":"R24-4-20210202","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1086\/420742","article-title":"Aminoglycoside toxicity: daily versus thrice-weekly dosing for treatment of mycobacterial diseases.","volume":"38","author":"Peloquin","year":"2004","journal-title":"Clin Infect Dis"},{"key":"R25-4-20210202","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1056\/NEJMc0806396","article-title":"Prevalence of mitochondrial 1555A-G mutation in European children.","volume":"360","author":"Bitner-Glindzicz","year":"2009","journal-title":"N Engl J Med"},{"key":"R26-4-20210202","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0165-5876(01)00455-4","article-title":"Evoked otoacoustic emissions\u2013an approach for monitoring cisplatin induced ototoxicity in children.","volume":"59","author":"Stavroulaki","year":"2001","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"R27-4-20210202","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/00005537-199604000-00003","article-title":"Ototoxicity resulting from combined administration of cisplatin and gentamicin.","volume":"106","author":"Riggs","year":"1996","journal-title":"Laryngoscope"},{"key":"R28-4-20210202","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1128\/AAC.43.7.1549","article-title":"Prospective evaluation of the effect of an aminoglycoside dosing regimen on rates of observed nephrotoxicity and ototoxicity.","volume":"43","author":"Rybak","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"R29-4-20210202","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1001\/jama.1977.03280040047019","article-title":"Tissue persistence of gentamicin in man.","volume":"238","author":"Schentag","year":"1977","journal-title":"JAMA"},{"key":"R30-4-20210202","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/00007691-200310000-00012","article-title":"The use of a change in gentamicin clearance as an early predictor of gentamicin-induced nephrotoxicity.","volume":"25","author":"Kirkpatrick","year":"2003","journal-title":"Ther Drug Monit"},{"key":"R31-4-20210202","article-title":"Guidelines for Preparing Core Clinical Safety Information on Drugs\u2013Report of CIOMS Working Group III, Chapter 5, Good Safety Information Practices.","year":"1995"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006454-201110000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T19:26:36Z","timestamp":1786044396000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006454-201110000-00004"}},"subtitle":["A Prospective Cohort Study Evaluating Safety and the Role of Therapeutic Drug Monitoring in Minimizing Toxicity"],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0b013e31821e405d","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}